Ivano Eberini

Prof. Dr. Ivano Eberini

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Biophysical Journal
Verified
Journal Article
Closed access
ARAlessandro Guerini Rocco
Alessandro Guerini Rocco
LMLuca Mollica
Luca Mollica
PRPiero Ricchiuto
Piero Ricchiuto
ABAntónio M. Baptista
António M. Baptista
EGElisabetta Gianazza
Elisabetta Gianazza
IEIvano Eberini
Ivano Eberini

9 July 2011 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
IEIvano Eberini
Ivano Eberini
SIMONA DANIELESIMONA DANIELE
SIMONA DANIELE
CPChiara Parravicini
Chiara Parravicini
CSCristina Sensi
Cristina Sensi
MTMaria Letizia Trincavelli
Maria Letizia Trincavelli
MAMaria Abbracchio
Maria Abbracchio

28 January 2004 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
IEIvano Eberini
Ivano Eberini
ABAntónio M. Baptista
António M. Baptista
EGElisabetta Gianazza
Elisabetta Gianazza
FFFranca Fraternali
Franca Fraternali
TBTiziana Beringhelli
Tiziana Beringhelli

1 September 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Open access
JCJ.V. Cotterill
J.V. Cotterill
LPLuca Palazzolo
Luca Palazzolo
CRC. Ridgway
C. Ridgway
NPN. Price
N. Price
ERE. Rorije
E. Rorije
IEIvano Eberini
Ivano Eberini
With the aim of obtaining reliable estimates of Estrogen Receptor (ER) binding for diverse classes of compounds, a weight of evidence approach using estimates from a suite of in silico models was assessed. The predictivity of a simple Majority Consensus of (Q)SAR models was assessed using a test set of compounds with experimental Relative Binding Affinity (RBA) data. Molecular docking was also carried out and the binding energies of these compounds to the ERα receptor were determined. For a few selected compounds, including a known full agonist and antagonist, the intrinsic activity was determined using low-mode molecular dynamics methods. Individual (Q)SAR model predictivity varied, as expected, with some models showing high sensitivity, others higher specificity. However, the Majority Consensus (Q)SAR prediction showed a high accuracy and reasonably balanced sensitivity and specificity. Molecular docking provided quantitative information on strength of binding to the ERα receptor. For the 50 highest binding affinity compounds with positive RBA experimental values, just 5 of them were predicted to be non-binders by the Majority QSAR Consensus. Furthermore, agonist-specific assay experimental values for these 5 compounds were negative, which indicates that they may be ER antagonists. We also showed different scenarios of combining (Q)SAR results with Molecular docking classification of ER binding based on cut-off values of binding energies, providing a rational combined strategy to maximize terms of toxicological interest.

1 December 2014 in Cellular Signalling
Verified
Journal Article
Closed access
CSCristina Sensi
Cristina Sensi
SDSimona Daniele
Simona Daniele
CPChiara Parravicini
Chiara Parravicini
EZElisa Zappelli
Elisa Zappelli
VRVincenzo Russo
Vincenzo Russo
IEIvano Eberini
Ivano Eberini

25 March 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
Lorena PochiniLorena Pochini
Lorena Pochini
MICHELE GALLUCCIOMICHELE GALLUCCIO
MICHELE GALLUCCIO
lara consolelara console
lara console
Mariafrancesca ScaliseMariafrancesca Scalise
Mariafrancesca Scalise
IEIvano Eberini
Ivano Eberini
Cesare IndiveriCesare Indiveri
Cesare Indiveri
Inflammation is a physiological condition characterized by a complex interplay between different cells handled by metabolites and specific inflammatory-related molecules. In some pathological situations, inflammation persists underlying and worsening the pathological state. Over the years, two membrane transporters namely OCTN1 (SLC22A4) and OCTN2 (SLC22A5) have been shown to play specific roles in inflammation. These transporters form the OCTN subfamily within the larger SLC22 family. The link between these proteins and inflammation has been proposed based on their link to some chronic inflammatory diseases such as asthma, Crohn’s disease (CD), and rheumatoid arthritis (RA). Moreover, the two transporters show the ability to mediate the transport of several compounds including carnitine, carnitine derivatives, acetylcholine, ergothioneine, and gut microbiota by-products, which have been specifically associated with inflammation for their anti- or proinflammatory action. Therefore, the absorption and distribution of these molecules rely on the presence of OCTN1 and OCTN2, whose expression is modulated by inflammatory cytokines and transcription factors typically activated by inflammation. In the present review, we wish to provide a state of the art on OCTN1 and OCTN2 transport function and regulation in relationships with inflammation and inflammatory diseases focusing on the metabolic signature collected in different body districts and gene polymorphisms related to inflammatory diseases.